Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Haiyi Pharmaceutical is a pharmaceutical manufacturing company based in Xinmin, Shenyang, China. Acquired by Beijing Haiyi Pharmaceutical in May 2023, the company was formerly known as Liaoning Yibang Pharmaceutical. It operates a large-scale production facility dedicated to the research, development, and manufacturing of traditional Chinese medicine oral solid preparations, small molecule active pharmaceutical ingredients (APIs), and advanced chemical intermediates. The company possesses dozens of drug approvals, including national essential drugs, and provides contract manufacturing and process optimization services for clinical-stage and commercial-stage therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Haiyi Pharmaceutical.